Cyaonoside B is primarily studied for its potential anti-inflammatory and neuroprotective properties. It has shown activity in modulating signaling pathways associated with oxidative stress and neuronal damage, making it a compound of interest in research on neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. Additionally, it exhibits inhibitory effects on certain pro-inflammatory cytokines, suggesting possible applications in developing treatments for chronic inflammatory disorders. Its natural origin and structural characteristics also make it a candidate for use in cosmetic formulations aimed at skin protection and anti-aging. Current applications remain largely within preclinical research, focusing on pharmacological development and mechanism validation.